Zobrazeno 1 - 10 of 589 pro vyhledávání: '"Peshwa MV"'
1
Akademický článek
Preclinical evaluation for engraftment of CD34 + cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models.
Autor: Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.; Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Li L; MaxCyte, Gaithersburg, MD, USA., Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Drysdale CM; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Gamer J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Leonard A; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Bonifacino AC; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Allen C; MaxCyte, Gaithersburg, MD, USA., Peshwa MV; MaxCyte, Gaithersburg, MD, USA., De Ravin SS; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Malech HL; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.
Publikováno v: Cell reports. Medicine [Cell Rep Med] 2021 Apr 20; Vol. 2 (4), pp. 100247. Date of Electronic Publication: 2021 Apr 20 (Print Publication: 2021).
Zobrazit plný text záznamu
2
Akademický článek
Nanotechnology for boosting ovarian cancer immunotherapy.
Autor: Kaur, Prabhjot1 (AUTHOR), Singh, Santosh Kumar1 (AUTHOR), Mishra, Manoj K.2 (AUTHOR), Singh, Shailesh1,3 (AUTHOR), Singh, Rajesh1,3 (AUTHOR) rsingh@msm.edu
Publikováno v: Journal of Ovarian Research. 10/14/2024, Vol. 17 Issue 1, p1-21. 21p.
Zobrazit plný text záznamu
3
Akademický článek
Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery.
Autor: McErlean, Emma M.1 (AUTHOR) e.mcerlean@qub.ac.uk, McCarthy, Helen O.1,2,3 (AUTHOR)
Publikováno v: Journal of Nanobiotechnology. 9/10/2024, Vol. 22 Issue 1, p1-28. 28p.
Zobrazit plný text záznamu
4
Akademický článek
Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy.
Autor: Hung CF; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland.; 2 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, Maryland., Xu X; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland., Li L; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Ma Y; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland., Jin Q; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland., Viley A; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Allen C; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Natarajan P; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Shivakumar R; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Peshwa MV; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Emens LA; 2 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, Maryland.; 4 Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy , Baltimore, Maryland.
Publikováno v: Human gene therapy [Hum Gene Ther] 2018 May; Vol. 29 (5), pp. 614-625. Date of Electronic Publication: 2018 Apr 02.
Zobrazit plný text záznamu
5
Akademický článek
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.
Autor: De Ravin SS; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. sderavin@niaid.nih.gov hmalech@nih.gov., Li L; MaxCyte Inc., Gaithersburg, MD 20878, USA., Wu X; Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick, MD 21701, USA., Choi U; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Allen C; MaxCyte Inc., Gaithersburg, MD 20878, USA., Koontz S; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Lee J; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Theobald-Whiting N; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Chu J; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Garofalo M; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Sweeney C; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Kardava L; Laboratory of Immunoregulation, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Moir S; Laboratory of Immunoregulation, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Viley A; MaxCyte Inc., Gaithersburg, MD 20878, USA., Natarajan P; MaxCyte Inc., Gaithersburg, MD 20878, USA., Su L; Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick, MD 21701, USA., Kuhns D; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Zarember KA; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Peshwa MV; MaxCyte Inc., Gaithersburg, MD 20878, USA., Malech HL; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. sderavin@niaid.nih.gov hmalech@nih.gov.
Publikováno v: Science translational medicine [Sci Transl Med] 2017 Jan 11; Vol. 9 (372).
Zobrazit plný text záznamu
6
Akademický článek
Co-culture engineering: a promising strategy for production of engineered extracellular vesicle for osteoarthritis treatment.
Autor: Esmaeili, Abazar1 (AUTHOR), Hosseini, Samaneh1,2 (AUTHOR) hosseini.samaneh@royaninstitute.org, Baghaban Eslaminejad, Mohamadreza1 (AUTHOR) eslami@royaninstitute.org
Publikováno v: Cell Communication & Signaling. 1/10/2024, Vol. 22 Issue 1, p1-15. 15p.
Zobrazit plný text záznamu
7
Akademický článek
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease.
Autor: De Ravin SS; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Reik A; Sangamo BioSciences, Inc., Richmond, California, USA., Liu PQ; Sangamo BioSciences, Inc., Richmond, California, USA., Li L; MaxCyte, Inc., Gaithersburg, Maryland, USA., Wu X; Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Su L; Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Raley C; Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Theobald N; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Choi U; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Song AH; Sangamo BioSciences, Inc., Richmond, California, USA., Chan A; Sangamo BioSciences, Inc., Richmond, California, USA., Pearl JR; Sangamo BioSciences, Inc., Richmond, California, USA., Paschon DE; Sangamo BioSciences, Inc., Richmond, California, USA., Lee J; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Newcombe H; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Koontz S; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Sweeney C; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Shivak DA; Sangamo BioSciences, Inc., Richmond, California, USA., Zarember KA; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Peshwa MV; Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Gregory PD; Sangamo BioSciences, Inc., Richmond, California, USA., Urnov FD; Sangamo BioSciences, Inc., Richmond, California, USA., Malech HL; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v: Nature biotechnology [Nat Biotechnol] 2016 Apr; Vol. 34 (4), pp. 424-9. Date of Electronic Publication: 2016 Mar 07.
Zobrazit plný text záznamu
8
Akademický článek
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19.
Autor: Carlsten M; Laboratory of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA., Levy E; Laboratory of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA., Karambelkar A; Laboratory of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA., Li L; MaxCyte Inc. , Gaithersburg, MD , USA., Reger R; Laboratory of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA., Berg M; Laboratory of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA., Peshwa MV; MaxCyte Inc. , Gaithersburg, MD , USA., Childs RW; Laboratory of Transplantation Immunotherapy, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA.
Publikováno v: Frontiers in immunology [Front Immunol] 2016 Mar 22; Vol. 7, pp. 105. Date of Electronic Publication: 2016 Mar 22 (Print Publication: 2016).
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje